» Articles » PMID: 30996683

Feasibility of Deep Learning for Predicting Live Birth from a Blastocyst Image in Patients Classified by Age

Overview
Journal Reprod Med Biol
Specialty Biology
Date 2019 Apr 19
PMID 30996683
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To identify artificial intelligence (AI) classifiers in images of blastocysts to predict the probability of achieving a live birth in patients classified by age. Results are compared to those obtained by conventional embryo (CE) evaluation.

Methods: A total of 5691 blastocysts were retrospectively enrolled. Images captured 115 hours after insemination (or 139 hours if not yet large enough) were classified according to maternal age as follows: <35, 35-37, 38-39, 40-41, and ≥42 years. The classifiers for each category and a classifier for all ages were related to convolutional neural networks associated with deep learning. Then, the live birth functions predicted by the AI and the multivariate logistic model functions predicted by CE were tested. The feasibility of the AI was investigated.

Results: The accuracies of AI/CE for predicting live birth were 0.64/0.61, 0.71/0.70, 0.78/0.77, 0.81/0.83, 0.88/0.94, and 0.72/0.74 for the age categories <35, 35-37, 38-39, 40-41, and ≥42 years and all ages, respectively. The sum value of the sensitivity and specificity revealed that AI performed better than CE ( = 0.01).

Conclusions: AI classifiers categorized by age can predict the probability of live birth from an image of the blastocyst and produced better results than were achieved using CE.

Citing Articles

Predicting IVF live -birth probability using time-lapse data: Implications of including or excluding age in a day 2 embryo transfer model.

Sayed S, Petersen B, Reigstad M, Schwennicke A, Hausken J, Storeng R PLoS One. 2025; 20(2):e0318480.

PMID: 39999051 PMC: 11856505. DOI: 10.1371/journal.pone.0318480.


Predicting implantation by using dual AI system incorporating three-dimensional blastocyst image and conventional embryo evaluation parameters-A pilot study.

Miyagi Y, Habara T, Hirata R, Hayashi N Reprod Med Biol. 2024; 23(1):e12612.

PMID: 39351129 PMC: 11442056. DOI: 10.1002/rmb2.12612.


Quality of IVM ovarian tissue oocytes: impact of clinical, demographic, and laboratory factors.

Kashutina M, Obosyan L, Bunyaeva E, Zhernov Y, Kirillova A J Assist Reprod Genet. 2024; 41(11):3079-3088.

PMID: 39349891 PMC: 11621277. DOI: 10.1007/s10815-024-03234-2.


Deep learning versus manual morphology-based embryo selection in IVF: a randomized, double-blind noninferiority trial.

Illingworth P, Venetis C, Gardner D, Nelson S, Berntsen J, Larman M Nat Med. 2024; 30(11):3114-3120.

PMID: 39122964 PMC: 11564097. DOI: 10.1038/s41591-024-03166-5.


Industry 4.0 Technologies in Maternal Health Care: Bibliometric Analysis and Research Agenda.

Sibanda K, Ndayizigamiye P, Twinomurinzi H JMIR Pediatr Parent. 2024; 7:e47848.

PMID: 39116433 PMC: 11342010. DOI: 10.2196/47848.


References
1.
Kudva V, Prasad K, Guruvare S . Automation of Detection of Cervical Cancer Using Convolutional Neural Networks. Crit Rev Biomed Eng. 2018; 46(2):135-145. DOI: 10.1615/CritRevBiomedEng.2018026019. View

2.
Hong Y, Kim S, Moon K, Kim S, Jee B, Lee W . Impact of presence of antiphospholipid antibodies on fertilization outcome. Obstet Gynecol Sci. 2018; 61(3):359-366. PMC: 5956119. DOI: 10.5468/ogs.2018.61.3.359. View

3.
Kroon S, Ravel J, Huston W . Cervicovaginal microbiota, women's health, and reproductive outcomes. Fertil Steril. 2018; 110(3):327-336. DOI: 10.1016/j.fertnstert.2018.06.036. View

4.
Finn A, Scott L, OLeary T, Davies D, Hill J . Sequential embryo scoring as a predictor of aneuploidy in poor-prognosis patients. Reprod Biomed Online. 2010; 21(3):381-90. DOI: 10.1016/j.rbmo.2010.05.004. View

5.
Shirasuna K, Iwata H . Effect of aging on the female reproductive function. Contracept Reprod Med. 2017; 2:23. PMC: 5683335. DOI: 10.1186/s40834-017-0050-9. View